Published in Medical Letter on the CDC and FDA, February 24th, 2008
The MAB pointed to new preclinical studies in second dosing of Oxycyte, sickle cell disease, spinal-cord injury, and continued support of the U.S. Navy's interest in decompression sickness, commonly know as bends, as valuable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.